IPAMORELIN / TESAMORELIN 5mg/5mg
The combination of Ipamorelin and Tesamorelin merges two potent growth-hormone–related research pathways: ghrelin-receptor stimulation and GHRH-based GH release. Together, they create a multi-dimensional model for exploring anabolic signaling, metabolic balance, and tissue-repair physiology. This peptide has ideal research in these categories:
- – Muscle Growth & Performance
- – Recovery & Repair
- – Metabolic Support
- – Anti-Aging
Understanding This Peptide
Ipamorelin selectively activates ghrelin receptors to stimulate GH pulses. Tesamorelin, a stabilized GHRH analogue, promotes GH release while influencing IGF-1 pathways. Their combined activity provides both frequency (Ipamorelin) and amplitude (Tesamorelin) in GH-release cycles.
Mechanism of Action
Ipamorelin triggers GH pulses through ghrelin-receptor activation. Tesamorelin binds GHRH receptors to amplify GH output and support IGF-1 modulation. Together, they generate a more robust, multi-layered GH response ideal for advanced metabolic and anabolic research.
Scientific Interest
Researchers appreciate this pairing for its ability to mimic the natural GH/IGF-1 axis in a dynamic way. Combining a GHRH analogue with a ghrelin mimetic allows investigators to explore GH interactions with greater precision.
Research Focus & Clinical Landscape
Active areas of investigation include:
- – GH pulsatility and amplitude
- – IGF-1 modulation
- – metabolic regulation
- – cellular repair and regeneration
- – sleep and recovery pathways
- – body-composition research
This combination has gained traction in metabolic and performance-recovery science.
Quality, Craftsmanship & Purity
Both peptides exceed >98% purity and are developed under GMP manufacturing practices. Stability and potency are confirmed through advanced analytical testing.
Final Insight
Ipamorelin/Tesamorelin offers a comprehensive GH-axis model that continues to shape the landscape of metabolic and regenerative research.